Active — Not RecruitingNot Applicable

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)

Germany2,000 participantsStarted 2023-05-04

Plain-language summary

The study aims to assess contemporary practice in OCT use during routine interven-tional practice and to assess the impact of the MLD-MAX algorithm on real-world PCI in a large unselected European all-comer-study cohort.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Patients with evidence of myocardial ischemia (e.g. stable angi-na, silent ischemia, unstable angina, or acute myocardial infarc-tion) undergoing OCT-guided lesion evaluation (OCT-scan using the devices must be performed either to guide PCI (following the MLD-MAX-algorithm) or to investigate a coronary lesion for fur-ther clinical treatment) * Written informed consent (defined as legally effective, docu-mented confirmation of a subject's (or their legally authorized representative or guardian) voluntary agreement to participate in a particular clinical study) to participate in this clinical inves-tigation Exclusion Criteria: * none

What they're measuring

Stent expansion: number of participants with optimal / acceptable / unacceptable stent expansion

Timeframe: At baseline

Trial details

NCT IDNCT05324683

SponsorIHF GmbH - Institut für Herzinfarktforschung

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04

View on ClinicalTrials.gov More Myocardial Ischemia trials